HCV-IN-39
HCV-IN-39 (Compound 18a) is a potent hepatitis C virus (HCV) nucleoside inhibitor with EC50 values of 0.644, 0.952 and 0.154 μM against GT1a, GT1b and GT1b CES1 replicons[1].
Product Specifications
CAS Number
2087916-31-0
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hcv-in-39.html
Solubility
10 mM in DMSO
Smiles
CCOC(C(C)(N[P@](OC[C@H]1O[C@H]([C@](Br)([C@@H]1O)Cl)N2C=CC(NC2=O)=O)(OC3=CC=CC=C3)=O)C)=O
Molecular Formula
C21H26BrClN3O9P
Molecular Weight
610.78
References & Citations
[1]Chris Krueger A, et al. Synthesis and evaluation of 2'-dihalo ribonucleotide prodrugs with activity against hepatitis C virus. Bioorg Med Chem. 2020 Jan 1;28 (1) :115208.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
132547-ML490 100 µL
RHCG (Rhesus Blood Group Family Type C Glycoprotein, Rh Family Type C Glycoprotein, Rh Type C Glycoprotein, Ammonium Transporter Rh Type C, C15orf6, CDRC2, PDRC2, Rh Glycoprotein Kidney, RHGK, SLC42A3, Tumor-related Protein DRC2) (MaxLight 490)
Sign In for Pricing
View Details